A randomized phase II, open-label study of sipuleucel-T with concurrent or sequential abiraterone acetate (AA) in metastatic castrate-resistant prostate cancer (mCRPC) Meeting Abstract

cited authors

  • Small, Eric Jay; Lance, Raymond; Gardner, Thomas A.; Karsh, Lawrence Ivan; Stubbs, Andrew; McCoy, Candice; DeVries, Todd; Redfern, Charles H.; Shore, Neal D.

Publication Date

  • February 20, 2013

webpage

published in

category

volume

  • 31

issue

  • 6